Profund Advisors LLC Vanda Pharmaceuticals Inc. Transaction History

Profund Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$5.9 - $6.95 $17,941 - $21,134	-3,041 Reduced 6.66%	42,644 $281,000
Q1 2023 May 11, 2023	BUY	$6.18 - $7.99 $282,333 - $365,023	45,685 New	45,685 $310,000
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $166,624 - $230,885	-10,855 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$15.71 - $21.51 $170,532 - $233,491	10,855 New	10,855 $231,000
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $277,148 - $489,223	-15,756 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $171,299 - $284,174	-9,030 Reduced 36.43%	15,756 $412,000
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $452,344 - $570,078	24,786 New	24,786 $569,000

155

43.7M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $252M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.